* Aethlon Medical Inc AEMD.OQ reported a quarterly
adjusted loss
of 26 cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 14 cents per share.
* Revenue fell 61.8% to $13.00 thousand from a year ago;
analysts
expected $721.00 thousand.
* Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 26 cents.
* The mean earnings estimate of analysts had risen by
about 17.6%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Aethlon Medical Inc shares had fallen by 27.4% this
quarter and
lost 43.0% so far this year.
* The company reported a quarterly loss of $3.79 million.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $8.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated June 28 at 09:16 p.m. All
figures in US dollars unless otherwise stated